To study the effects of EPO in AD mouse models via a non-invasive transvascular route of administration, an MTH-EPO fusion protein was engineered using a rat/mouse chimeric antibody directed against the mouse TfR (cTfRMAb) and EPO [13]. Here, EPO is linked to Alzheimer disease.